|
Omalizumab reduces exacerbation rate in children with asthma
Healio Teach and colleagues conducted a double blind, double placebo-controlled study of 478 children with asthma aged 6 to 17 years old who lived in the inner city. Study participants — all of whom had a recent asthma exacerbation — were randomly assigned … |
View full post on asthma – Google News